Loading asset research
Alpha Tau Medical Ltd. Ordinary Shares
DRTSNasdaq · USD · StocksQuote as of · Exchange session not verified$14.52
-0.00%
Today
DRTS
Loading 1D prices…
Market cap
$1.4B
Volume
467K
52w high
$15.7952w low
$3.43Company profile
Alpha Tau Medical Ltd. Ordinary Shares
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Jerusalem, Israel, United States
Employees
121
Fiscal year end
1231
CIK
1871321
Session & valuation
Open$14.50
Previous close$14.52
Day high$14.80
Day low$14.31
30-day avg. volume608.1K
Outstanding shares88M
Diluted EPS-$0.53
Latest annual period
P/E (trailing)-27.40
P/E (forward)-27.63
Price / book30.96
Beta1.21
Dividend yield—
Deterministic peer set
Companies with SEC SIC 3841
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| IARTIntegra LifeSciences Holdings Corporation Common Stock | $1.2B | $1.6B | -31.60% | -$6.74 | +3.22% | Hold |
| ATECAlphatec Holdings Inc. Common Stock | $1.5B | $764.2M | -18.76% | -$0.96 | +2.59% | Buy |
| KMTSKestra Medical Technologies Ltd. Common Stock | $1.5B | $95.1M | -138.36% | -$2.43 | +0.98% | Buy |
| BBNXBeta Bionics Inc. Common Stock | $1.2B | $100.3M | -73.02% | -$1.81 | -1.92% | Buy |
| AORTArtivion Inc. Common Stock | $1.1B | $441.3M | +2.21% | $0.21 | -1.78% | Buy |